Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.
Posters
Growth kinetics and immune cell profiling of BT-474 human breast carcinoma and Raji-Luc human Burkitt's lymphoma in four strains of triple immunodeficient mice
AACR 2023 -- Triple immunodeficient mouse models are often necessary to evaluate xenograft models and adoptive cell therapies using human immune cells. Triple immunodeficient mice lack functional T cells, B cells and natural killer (NK) cells. Female NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice, NOD.CB17-Prkdcscid IL2rgtm1/BcgenHsd (B-NDG) mice, NOD-Prkdcem26Cd52Il2rgem26Cd22/NjuCrl (NCG) mice and NOD.Cg-Prkdcscid Il2rgtm1Sug/JicTac (CIEA NOG) mice were implanted with subcutaneous BT-474 or systemic Raji-Luc to evaluate growth kinetics and to collect samples to assess immune cell profiles. Disease induction and growth parameters were determined through previous experience and optimization studies with subcutaneous BT-474 and systemic Raji-Luc (data not shown). Blood, spleen and tumor samples were collected from mice implanted with BT-474 and blood, spleen and bone marrow samples were collected from mice implanted with Raji-Luc. Immune cell profiles were analyzed via flow cytometry to quantify lymphocyte and myeloid immune cell subsets and to observed differences between the four mouse strains.